STARMUS V, Host of The Stephen Hawking Medal, Hosts a Special Evening in Davos at WEF with Jean-Michel Jarre, Brian May and Luminary Scientific Panel
This year, WEF was treated to a rare panel discussion bridging the fields of astronomy and music. Global CEOs and international media had the opportunity to hear from Dr. Brian May, Jean-Michel Jarre and Dr. Garik Israelian discuss STARMUS and the special connection between science and music. Flanked by a panel of renowned scientists, astronauts, and Nobel laureates, Jean-Michel Jarre introduced his groundbreaking tribute to the Apollo Missions for their 50th Anniversary.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190124005171/en/
WEF panel for STARMUS, Michel Mayor, Jean-Michel Jarre, Garik Israelian, and moderator Marco Larsen engage with the Davos audience. Photo by: Andres Eggenberger
The esteemed panel included Swiss Astronaut Claude Nicollier, Garik Israelian, Brian May, and Michel Mayor. (Special thanks to the support from Kaspersky Labs and to the Stephen Hawking Medal for Science Communication sponsor, Omega.)
The event drew many of the world’s CEOs and music fans in Davos for The World Economic Forum eager to hear about the new musical tribute to the 50 Year Anniversary of Apollo Missions by Jean-Michel Jarre.
“For the first time, the use of ‘star sounds’ library developed by Dr. Garik Israelian will be incorporated into composed music. While it’s a relatively unknown phenomenon, it is no doubt real. I’m excited to include the actual sounds of planets and stars in this groundbreaking ode to the Apollo Missions.” - Jean-Michel Jarre.
ABOUT STARMUS V:
Fans from around the globe will descend on Zurich, Switzerland from June 24-29, 2019, to celebrate STARMUS V - the world’s most notable science and art festival. This year promises to be the most important program to date, coinciding with the 50th anniversary of the moon landings, one of science’s most important milestones. STARMUS V will also host a special ceremony announcing the 2019 Stephen Hawking Medal for Science Communication winners, supported by Omega and Kaspersky Labs.
Jean-Michel Jarre will headline a concert with “star sounds” never before heard here on earth. In addition to astronaut Michael Collins joining as the keynote, STARMUS V will host a remarkable line-up of presenters hand-selected by the STARMUS board (Stephen Hawking posthumous, May-Brit Moser, Elizabeth Blackburn, Linda Buck, Brian May, Peter Gabriel, Richard Dawkins, Alexei Leonov, Jill Tarter, Robert Williams, David Eicher, Emmanuelle Charpentier and founder, Garik Israelian). The 2019 festival STARMUS V will also feature seven of the original Apollo Mission crew, science legend and champion Bill Nye along with rock stars Brian May, Brian Eno, Steve Vai, and Rick Wakeman.
And as a special homage to the Apollo Missions and those who made them possible, Hans Zimmer will be performing a very special concert “Once Upon a Time on The Moon.”
According to Garik Israelian, STARMUS founder, the 2019 festival has been designed to ask tough questions about our place in the universe at a pivotal point in human history: “The importance of STARMUS V cannot be understated. At a time when the world retreats to isolationism, collaboration is needed to strategically present the ideas, evidence, and challenges we collectively face – and uniquely confront. We believe the biggest and best achievements of the human race are a result of that scientific collaboration.”
STARMUS V will welcome 12 Nobel laureates to the stage, as well as luminaries from the worlds of art and music, for six days of discussion, debate, and engagement across the sciences, from microbiology and biochemistry to astrophysics and neuroscience. The 2019 programme will bring together some of the most intelligent, creative, and artistic people on the planet.
Other speakers include Sir Martin Rees, Brian Cox, Emmanuelle Charpentier, and Helen Sharman.
Tickets are now officially on sale and can be purchased at www.starmus.com.
STARMUS V HONORED PARTNERS
OMEGA and The Stephen Hawking Medal:
OMEGA is a prestigious Swiss watchmaker and member of the Swatch Group Ltd. Since 1848, the brand has been synonymous with excellence, innovation, and precision, as well as a pioneering spirit, demonstrated by its achievements in sports timekeeping, the oceans, and space. In fact, since 1965, the OMEGA Speedmaster has been worn on each of NASA's manned missions including all six moon landings.
Kaspersky Lab is a global cybersecurity company, which has been operating in the market for 21 years. Kaspersky Lab’s deep threat intelligence and security expertise are constantly transforming into next-generation security solutions and services to protect businesses, critical infrastructure, governments and consumers around the globe. The company’s comprehensive security portfolio includes leading endpoint protection and a number of specialized security solutions and services to fight sophisticated and evolving digital threats. Over 400 million users are protected by Kaspersky Lab technologies and we help 270,000 corporate clients protect what matters most to them. Learn more at www.kaspersky.com.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WEYTEC and Raytheon Team Up to Enhance Air Traffic Management Technology21.10.2019 19:23:00 EEST | Press release
WEY Technology (WEYTEC) and Raytheon Company (NYSE: RTN) have signed a teaming agreement to co-develop the next-generation air traffic controller workplaces called Multi-platform ATC Re-hosting Solution, or MARS. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191021005591/en/ ATC Workplaces of the Future (Photo: Business Wire) Today in the U.S., air traffic controllers use Raytheon's Standard Terminal Automation Replacement System, or STARS, to provide safe and efficient aircraft spacing and sequencing guidance for more than 40,000 departing and arriving aircraft daily at both civilian and military airports. WEYTEC brings smart tech to airport command and control centers around the world through the transmission, control, distribution and display of real-time data critical to efficient flight operations. "Our integrated KVM solutions are autonomous, scalable, and IP-based, which makes them ideal for complex multiscreen workp
Tommy Hilfiger Appoints Michael Scheiner as Global Chief Marketing Officer21.10.2019 18:15:00 EEST | Press release
Tommy Hilfiger, which is owned by PVH Corp. [NYSE: PVH], is pleased to announce the appointment of Michael Scheiner as Chief Marketing Officer, Tommy Hilfiger Global, effective October 28, 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191021005511/en/ Michael Scheiner, Chief Marketing Officer, Tommy Hilfiger Global (Photo: Business Wire) Michael has amassed over 15 years of experience at global brands. He joins Tommy Hilfiger from Hollister Co., where he served as SVP, Global Marketing. His work helped to move Hollister into the top 5 brands among teens in Piper Jaffray’s Fall 2019 Taking Stock survey, and supported Hollister’s recognition as a Top Omni-Channel retailer. Michael will utilize his passion and experience to lead TOMMY HILFIGER into a new era of innovative marketing strategies – particularly across digital and experiential platforms – to reach and engage the next generation of consumers. “As one of the wo
Workiva Named Large Software Company of the Year by International Business Awards®21.10.2019 16:03:00 EEST | Press release
Workiva (NYSE:WK), provider of the world’s leading connected reporting and compliance platform, has won a Gold Stevie® Award for Company of the Year in the large software company category in The 16th Annual International Business Awards®. The awards were presented at a gala ceremony in Vienna, Austria on October 19. “Workiva is honored to be recognized globally with a Gold Stevie Award,” said Marty Vanderploeg, CEO of Workiva. “We give our employees the freedom and resources they need – backed by our culture of collaboration and inclusion – to help our customers around the world build trust with connected reporting." The International Business Awards are the world’s premier business awards program. A record total of more than 4,000 nominations from organizations of various sizes and industries in 74 nations and territories were submitted this year for consideration in a wide range of categories. More than 250 executives worldwide served as Stevie Awards judges from May through August.
Mavenir Demonstrates Automated Deployment of Cloud-Native 5G Core at MWC LA21.10.2019 16:00:00 EEST | Press release
Mobile World Congress: Mavenir, a US-based Network Software Provider, and the industry's only end-to-end cloud-native vendor for CSPs, announced today its 5G Core platform, which includes a comprehensive set of 5G core functions on a containerized cloud-native platform. The decomposition of functions into these modular units provides the operators the flexibility to scale them independently; scalability and flexibility that wasn’t possible with 4G EPC. Mavenir has invested heavily in developing the 5G Core solution from the ground-up on cloud-native principles that can still be retrofitted on EPCs. The solution encompasses all the major 5G core elements, such as AMF, SMF, UPF, NRF, UDSF, PCF, UDM, UDR, NSSF, AUSF, BSF, N3IWF, SCP, SEPP, and SMSF. All these functions are implemented as micro-services in containers. In addition, Mavenir is also building remaining 5G core functions, NEF, 5G-EIR, NWDAF etc. The Mavenir 5G Core also combines 4G EPC functionality and offers a ‘Converged Mobi
ResMed Introduces AirFit N30, World’s First Tube-Down Nasal Cradle CPAP Mask21.10.2019 16:00:00 EEST | Press release
ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea treatment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191021005138/en/ ResMed AirFit N30, tube-down nasal cradle CPAP mask (Photo: Business Wire) ResMed’s lightest mask yet, AirFit N30 features an adjustable elastic headgear, plus a nasal cradle cushion that sits under the nasal bridge, eliminating soreness in that area. The mask’s curved cushion is designed to provide a secure seal regardless of how the wearer sleeps or moves. Together, these innovations help make starting and staying on CPAP therapy easier than ever for more of the 936 million people worldwide living with sleep apnea. “AirFit N30 is about ease of use, helping people ease into therapy and addressing the most common pain points for longtime users,” said Jim Hollingshead, president of R
STELARA® (ustekinumab) Data Demonstrate Long-term Efficacy and Safety Results in Adults With Moderately to Severely Active Ulcerative Colitis in Phase 3 Extension Trial21.10.2019 15:12:00 EEST | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new two-year data from the long-term extension of the Phase 3 UNIFI study, demonstrating the efficacy and safety of ustekinumab through two years of treatment in adults with moderately to severely active ulcerative colitis (UC). These data are being presented today as a late-breaking data presentation (LB01) at the 27th UEGW congress.1 These data include 399 participants who were in clinical response eight weeks after receiving a single intravenous (IV) induction dose of ustekinumab and who were then randomised to receive ustekinumab subcutaneous (SC) 90 mg injections every 12 weeks (q12w), ustekinumab SC 90 mg injections every 8 weeks (q8w), or placebo, and who were treated in the long-term extension.1 Results showed that the majority of patients were able to sustain remission through to week 92 as assessed by symptomatic remission. The percentage of patients receiving ustekinumab SC who were in symptomatic remi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom